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Abstract
Background: Non-motor symptoms can be present in essential tremor (ET). We intend to assess the frequency of rapid eye movement (REM) sleep behavior disorder
(RBD) and dysautonomic symptoms in ET patients and evaluate the differences between patients with ET and RBD (ET-RBD and ET without RBD [ET-nonRBD]).
Methods: All ET patients were contacted by telephone. Autonomic symptoms were assessed using the Scales for Outcomes in Parkinson’s Disease-Autonomic
(SCOPA-AUT) questionnaire, and RBD symptoms with the RBD screening questionnaire (RBDSQ) using >5 as a cut-off for probable RBD (pRBD).
Results: From 92 ET patients contacted, 53 (55% female) were included. The mean age at assessment was 73.6¡19 years, and the average disease duration was
19.9¡17.3 years. Fourteen patients (26.4%) had pRBD and 52 (98.1%) reported at least one autonomic symptom, the most prevalent being urinary symptoms (96%).
The ET-RBD group had higher SCOPA-total and thermoregulatory scores than ET-nonRBD patients (13.9¡9.6 vs. 7.7¡5.1, p50.017 and 2.5¡2.0 vs. 0.9¡1.6,
p50.001). There were no other differences between groups.
Discussion: Our results suggest that pRBD is common in ET, and its presence is associated with dysautonomic symptoms. As these symptoms are known to be
prodromal symptoms of Parkinson’s disease (PD), we question if this patient subgroup has a higher risk of developing a synucleinopathy.
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Introduction
Essential tremor (ET) is the most common movement disorder.1
Although classically described as a motor disease, several non-motor
symptoms (NMS) have been consistently associated with ET,2 sup-
porting changing the paradigm from a monosymptomatic disorder to a
disease affecting multiple motor and non-motor systems. Hearing
impairment,3 mild cognitive deficits, and neuropsychiatric disturbances
such as depression and anxiety are all frequently observed in patients
with ET.4,5 However, evidence on the association of ET with rapid
eye movement (REM) sleep behavior disorder (RBD)2 or autonomic
symptoms remains conflicting.2,9,10,11
Although previous studies have found that patients with ET have up
to a fourfold higher risk of developing Parkinson’s disease (PD), most
chronic ET patients do not develop additional motor symptoms
typically associated with PD, such as bradykinesia, rigidity, or postural
instability.12
As autonomic dysfunction and particularly RBD are known NMS
associated with the development of synucleinopathies such as PD,13,14
we studied the prevalence of these two NMS in ET patients. We also
investigated whether there was any difference between ET patients
with and without RBD regarding demographics, tremor character-
istics, and prevalence of autonomic symptoms.
Methods
We contacted by phone and reviewed the clinical files of all patients
who attended the Egas Moniz Hospital movement disorders outpatients’
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clinic in Portugal, with a diagnosis of ET during 2014. All patients had at
least two visits 6 months apart.
Verbal informed consent was obtained from all patients. This study
was approved by the research and ethics board of Centro Hospitalar
de Lisboa Ocidental.
ET was diagnosed by the movement disorders neurologist responsible
for the patients, according to the diagnostic criteria proposed by the
Tremor Investigation Group (TRIG), which require bilateral, largely
symmetric postural or kinetic tremor involving the upper limbs. Addi-
tional or isolated head tremor may occur in the absence of dystonic
postures.15 Patients who also fulfilled criteria for PD, Lewy body
dementia, or atypical parkinsonism were not included.
A structured clinical form was constructed for data collection. We
collected information regarding age at assessment, age of disease onset,
and disease duration (defined as actual age minus age at symptom
onset, as reported by the patient). We recorded locality of tremor onset
and symmetry of tremor at onset (a symmetrical onset was considered
if tremor started in both the upper or lower limbs, and an asym-
metrical onset was defined when tremor started in one limb or one
limb was clearly more affected than the other). Data about familial
history of tremor and actual treatment (medication taken for tremor
at the moment of the telephone interview) were also noted. We also
collected information about hypertension, diabetes mellitus, and benign
prostatic hyperplasia (BPH) diagnoses, as they can be associated with
autonomic symptoms.
Autonomic symptoms were assessed using the Scales for Outcomes
in Parkinson’s Disease-Autonomic (SCOPA-AUT) questionnaire. It is
divided into six domains: gastrointestinal, urinary, cardiovascular,
thermoregulatory, pupillomotor, and sexual. Each domain includes
seven, six, three, three, one, and two questions, respectively. Each auto-
nomic domain was scored as the frequency of symptom occurrence with
response options ranging from 0 (‘‘never’’) to 3 (‘‘often’’). The urinary
and sexual questions have an additional response option to indicate if
a subject used a catheter or had not been sexually active, respectively.
The total SCOPA score is the sum of values of gastrointestinal, urinary,
cardiovascular, thermoregulatory, and pupillomotor domains. The sex-
ual function domain was not included in further analysis since 27/53
(50.9%) of the patients answered ‘‘not sexually active’’ for one of the
sexual questions.17
The RBD screening questionnaire (RBDSQ) was used to assess
RBD symptoms. The cut-off for a probable RBD (pRBD) diagnosis is
>5, with a sensitivity of 96% and a specificity of 92%.16 According to
the RBDSQ results, we divided the patients into two groups of ET
patients with pRBD (ET-RBD) and without pRBD (ET-nonRBD),
knowing that RBD is a known marker of synucleinopathy.
Statistical analysis
Continuous variables are expressed as mean¡standard deviation
and were compared using the Mann-Whitney U test. Categorical var-
iables are expressed as percentages, and comparisons were performed
using the chi-squared test (Fisher’s exact test was used when chi-
squared assumptions were not fulfilled). P,0.05 was considered
statistically significant. Statistical analysis was performed using the
Statistical Package for Social Sciences (SPSS) 20.0 version software
package.
Results
From 92 ET patients, 53 (55% female) consented to participate and
completed the telephone interview. There were no significant diffe-
rences in age or sex between participants and non-participants (55%
vs. 46% female, p50.417; age 73.6¡11.0 vs. 78.2¡7.8, p50.076).
The mean age at assessment was 73.6¡11.0 years with a disease
duration of 19.9¡17.3 years. In most patients (58.5%), tremor started
before age 65. Forty-one (77.4%) patients were receiving treatment,
with primidone being the drug most prescribed (22 patients, 53.6%).
There were no differences in prescriptions between the ET-RBD and
ET-nonRBD groups. Almost all (98.1%, 95% confidence interval [CI]:
90.0–99.7%) patients reported at least one autonomic symptom (96%
urinary symptoms, 70% gastrointestinal, 42% cardiovascular, 53%
thermoregulatory, and 28% pupillomotor dysfunction), and 14/53
(26.4%, 95% CI: 16.4–39.6%) had a diagnosis of pRBD. Full group
data can be found in Table 1.
RBD patients had higher SCOPA-total scores (13.9¡9.6 vs. 7.7¡
5.1, p50.017) and higher thermoregulatory domain scores (2.5¡2.0 vs.
0.9¡1.6, p50.001) compared to ET-nonRBD. There were no other
differences between groups regarding age, age at onset, family history,
disease duration, or tremor characteristics (Table 1).
Regarding comorbidities, 20, 9, and 3 patients had hypertension,
diabetes, and BPH, respectively. When comparing the ET-RBD and
ET-nonRBD groups, there were no differences regarding the pre-
valence of comorbidities (Table 1). When comparing patients with
and without comorbidities , there was no difference in SCOPA total
score (8.7¡8.1 vs. 9.9¡5.9, p50.164) but patients with comor-
bidities had lower SCOPA-gastrointestinal (1.85¡2.78 vs. 2.85¡
2.28, p50.030) and SCOPA-pupillomotor scores (0.230¡0.651 vs.
0.406¡1.219, p50.028).
Discussion
The common view of ET as an exclusively motor and mono-
symptomatic disorder has been changing since NMS were first
described in ET patients. This suggests that the pathophysiology of
the disease involves more than the motor domain.
We found autonomic symptoms in virtually all ET patients. While
one study using the SCOPA-AUT only found a slight increase in
sialorrhea in ET patients compared to controls,9 another reported a
significantly higher rate of autonomic dysfunction in ET,10 with ET
patients presenting higher SCOPA-total, SCOPA-genitourinary, and
SCOPA-cardiovascular scores than controls. These findings reflect the
ongoing debate regarding autonomic dysfunction in ET. The presence
of autonomic dysfunction was studied using sympathetic skin response
(SSR) tests, in a group of 27 ET patients (mean age of 47.06 years) and
26 controls (mean age of 43.34). The authors found a higher
prevalence of abnormal SSR test results in ET patients than controls,
indicating sympathetic dysfunction in these patients.11
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Age, yrs 73.6 (¡11.0) 70.1 (¡15.5) 74.8 (¡8.6) 0.558
Female sex 29 (54.7%) 8 (57.1%) 21 (53.8%) 0.832
Age at onset, yrs 53.7 (¡20.3) 51.8 (¡22.6) 54.4 (¡19.8) 0.693
Onset before 65 yrs 31 (58.5%) 8 (57.1%) 23 (58.9%) 0.905
Disease duration, yrs 19.9 (¡17.3) 18.3 (¡15.8) 20.5 (¡18.0) 0.746






























































































Abbreviations: BPH, Benign Prostatic Hyperplasia; ET, Essential Tremor; RBD, Rapid Eye Movement Sleep Behavior Disorder;
RBDSQ, Rapid Eye Movement Sleep Behavior Disorder Screening Questionnaire; SCOPA-AUT, Scales for Outcomes in Parkinson’s Disease-Autonomic;
SD, Standard Deviation.
1Fisher’s exact t test.
2Head (n53), both lower limbs (n52).
3For total ET patients n550, for ET+RBD n513, for ET no RBD n537.
4Gabapentine (n52), alprazolam (n51), trihexyphenidyl (n51).
*p,0.05;
***p,0.005
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We are aware that the higher prevalence of autonomic symptoms in
our cohort may be influenced by other comorbidities that are common
in this age group. However, no association was found between higher
SCOPA-total and subdomain scores and the presence of comorbidities
(diabetes, hypertension, and BPH as a group). We also did not find any
association between the presence of RBD and comorbidities (Table 1).
pRBD was present in 26% of our ET patients. Mahlknecht and
collaborators18 also used the RBDSQ to assess the prevalence of pRBD
in the general population. In a cohort of 476 subjects (mean age of
72.8¡8.5 years, similar to our sample), they found 5.5% had pRBD.
This prevalence is lower than even the lower limit of our 95% CI. Our
results are similar to those of the only other study that used the RBDSQ
to assess patients with ET,2 which also found an increased prevalence
(43.5%) of this parasomnia. Although remaining below the prevalence
of RBD in well-known synucleinopathies, the rate of pRBD in our
ET patients seems to be closer to these patients than to the general
population.
Pathologic studies of ET brains have revealed at least two different
patterns of pathology: patients with degenerative changes in the cere-
bellum (including Purkinje cell loss) and patients presenting with brain-
stem Lewy bodies without cerebellar degeneration.19 Lewy bodies
are the pathological hallmark of synucleinopathies, which are known
to be related to RBD and autonomic symptoms. In fact, our data hint
at a relationship between RBD and dysautonomia in ET patients,
a well-documented phenomenon in non-ET subjects.20 These neuro-
pathological findings support the growing evidence of an association
between ET and PD, with some previous studies showing that ET
patients have a fourfold higher risk of developing PD than the general
population.12
Some studies have also compared the clinical characteristics of
ET patients who later developed PD (ETRPD) with those who did
not. Ghika and collaborator found that NMS like hyposmia, obsti-
pation, and RBD are more common in ETRPD patients than their
counterparts.8
RBD is a known prodromal marker of PD.13 We question if its
presence, which is associated with a higher rate of autonomic symp-
toms, could be a clinical marker of a higher risk of developing PD.
A recent study found NMS to be exceedingly frequent in ET and
unrelated to tremor severity and duration. The authors hypothesized
that NMS could be both primary symptoms of the disease process,
reflecting degeneration of various motor and non-motor neural systems,
and also analogous to neurodegenerative conditions like PD and part of
the premotor phase of ET.21
Our study has some limitations. The most significant is the lack of
a control group. We acknowledge this could add clinically relevant
information. Also, the patients were recruited from our outpatient
clinic (where more severe ET is encountered). Although it is not likely
that tremor severity is related with autonomic dysfunction or RBD,6
we cannot exclude the possibility of selection bias. We used a struc-
tured interview to minimize possible bias due to different people per-
forming the telephone interviews. In addition, the refusal of some
subjects to participate could have affected the lack of demographic
differences. We are also aware that other comorbidities could influence
autonomic symptoms and that inclusion of a control group could allow
us to make better comparisons. Regardless, the observed association
between RBD and autonomic symptoms severity is independent of this
comparison.
Despite these limitations, we found pRBD in ET patients, and these
individuals also had more autonomic symptoms. Our results back up
previous reports of an association between ET and neurodegenerative
disease (particularly PD).2,12 RBD and obstipation have previously
been associated with the ETRPD phenotype.8 We believe our data
indicate that the association of NMS in some ET patients is not by
chance but could represent a subgroup at higher risk for PD progression.
There is a need for more and collaborative studies in this area, with
larger numbers of patients and healthy control group subjects. It is also
important to test the hypothesis that ET can evolve non-uniformly
across patients. Long-term follow-up and neuropathological studies
would clarify the possible link between which NMS and clinical
characteristics of ET patients may predict conversion to PD.
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